Nexium advertorial dps_297x210mm_v1.indd
24-hour protection
from frequent heartburn
24h heartburn protection for less than £1 a day:
Frequent heartburn sufferers may need multiple daily doses to achieve long term relief, which can be costly.
With over 8 million adults in the UK experiencing heartburn
How quickly will Nexium
Heartburn medicines: a daily cost comparison
twice a week1 or more, their current medication might not
Nexium Control® gets to work
be meeting their needs.
in 1 hour and some people may
experience protection from
Did you know that 61% of people are dissatisfi ed with their current OTC heartburn treatment?
heartburn that day or by the
1 Many frequent heartburn
evening. Full effect may take
sufferers rely on antacids and alginates1, however, while these treatments provide immediate relief, they do not deliver the
Gaviscon peppermint tablets
sustained relief that frequent sufferers require as they last only 2 - 4 hours.2
Gaviscon Double Action
How long can I continuously
Rennie peppermint tablets
What is heartburn?
Nexium Control® is the only GSL medication to provide 24 hour relief
take Nexium Control® for?
Heartburn is a painful condition caused
Zantac 75 tablets
Nexium Control® can be taken
by stomach acid rising up (refl ux) into
for up to 14 days consecutively.4
the oesophagus. Symptoms include
Free CPD training: Managing Acid
a burning feeling behind the sternum
Refl ux: The Pharmacist's Role
and an acidic taste in the back of the
How often can I take
throat (acid regurgitation).
The new PROTECT e-learning programme focuses
Nexium Control®?
on key aspects of the modern management of acid refl ux and heartburn in community pharmacies.
What is frequent heartburn?
The dose is 1 tablet per day for
Through in-depth learning, patient case studies
up to 14 days.4 When your refl ux
Frequent heartburn and/ or acid refl ux
and practical downloadable tools, this educational
Antacids:
Alginates:
H2 blockers:
PPIs (Nexium Control):
symptoms have completely gone
means heartburn that happens twice
platform provides pharmacists and their teams with
Neutralises acid,
Forms a protective
Blocks one of the
you should stop taking Nexium
the knowledge, confi dence and practical guidance to
up to 2 hours
3 signals that stimulate
stomach contents,
acid production,
acid production,
support customer interactions and make appropriate
Control. If your refl ux symptoms
up to 4 hours
up to 12 hours
up to 24 hours
treatment recommendations.
get worse or do not improve
The programme takes around 30 minutes and can be
after taking this medicine for
completed online at
www.protect-cpd.com
Which treatment to recommend?
14 days in a row, see your GP.
Which treatment to recommend?
If symptoms return after 3
The appropriate treatment will depend on the FREQUENCY of your patient's heartburn.
Frequent heartburn is a common
months you may take Nexium
The appropriate treatment will depend on the FREQUENCY of your patient's heartburn:
condition:
Control® again.7
Nexium Control® can be taken for up to 14 consecutive days and is available in 7 (RRP £6.99) or 14 (RRP £11.99) tablet packs. Visit www.hcp.nexiumcontrol.co.uk for more details.
One in three adults in the UK suffer from
Frequent heartburn
Occasional heartburn
heartburn and one in six from frequent
(>2 times/ week)
(<2 times/ week)
heartburn, that is 8 million people.1
Name of product: Nexium Control 20 mg
liver disease. They are aged over 55 years with new or
days to achieve improvement of symptoms.
gastro-resistant tablets
recently changed symptoms. Patients with long term
The duration of treatment is up to 2 weeks.
Atypical reflux symptoms:
Typical reflux symptoms
recurrent symptoms of indigestion or heartburn should
Once complete relief of symptoms has occurred,
(heartburn, acid regurgitation)
Active ingredient: Esomeprazole
see their doctor at regular intervals. Especially, patients
treatment should be discontinued. If no symptom
On demand antacids/
UK ADULTS SUFFER FROM FREQUENT HEARTBURN
alginates or Ranitidine
Product licence numbers: EU/1/13/860/001
over 55 years taking any non prescription indigestion
relief is obtained within 2 weeks of continuous
• Pain or problems swallowing
and EU/1/13/860/002
or heartburn remedy on a daily basis should inform
treatment, the patient should be instructed to
• Stomach pain or signs of
their pharmacist or doctor. Patients should not take
consult a doctor. Dose adjustment is not required in
indigestion such as nausea or
Nexium treatment for up to 2 weeks
Name and address of the product licence holder:
Nexium Control as a long term preventive medicinal
patients with impaired renal function. Due to limited
bloating after food intake• Vomiting food or blood
Pfi zer Consumer Healthcare Ltd, Ramsgate Road,
product. Treatment with proton pump inhibitors (PPIs)
experience in patients with severe renal insuffi ciency,
• Over 55 and have new or recently
Sandwich, Kent, CT13 9NJ, UK
may lead to a slightly increased risk of gastrointestinal
such patients should be treated with caution. Dose
changed reflux symptoms
infections such as Salmonella and Campylobacter
adjustment is not required in patients with mild to
Supply classifi cation: General Sales List (GSL)
and in hospitalised patients, also possibly Clostridium
moderate liver impairment. However, patients with
Nexium Control®
Stop Nexium
Indications: The short term treatment of refl ux
diffi cile. Patients should consult their doctor before
severe liver impairment should be advised by a doctor
taking this medicinal product if they are due to have
before taking Nexium Control. Dose adjustment is
For 24h heartburn protection4
symptoms (e.g. heartburn and acid regurgitation)
an endoscopy or urea breath test. Co administration
not required in elderly patients. There is no relevant
of esomeprazole with atazanavir is not recommended
use of NEXIUM Control in the paediatric population
Symptoms return <3 months7
Side Effects: Common: headache, abdominal
(see section 4.5). If the combination of atazanavir with
below 18 years of age in the indication: "short-term
3 months7
pain, constipation, diarrhoea, fl atulence, nausea/
a PPI is judged unavoidable, close clinical monitoring is
treatment of refl ux symptoms (e.g., heartburn and
vomiting. Uncommon: peripheral oedema, insomnia,
recommended in combination with an increase in the
acid regurgitation)". The tablets should be swallowed
dizziness, paraesthesia, somnolence, vertigo, dry
dose of atazanavir to 400 mg with 100 mg of ritonavir.
whole with half a glass of water. The tablets must not
mouth, increased liver enzymes, dermatitis, pruritus,
Esomeprazole 20 mg should not be exceeded.
be chewed or crushed. Alternatively, the tablet can
rash urticaria. Rare: leukopenia, thrombocytopenia,
Esomeprazole is a CYP2C19 inhibitor. When starting
be dispersed in half a glass of non carbonated water.
hypersensitivity reactions e.g. fever, angioedema and
or ending treatment with esomeprazole, the potential
No other liquids should be used as the enteric coating
Feel confi dent recommending Nexium Control®
anaphylactic reaction/shock, hyponatraemia, agitation,
for interactions with medicinal products metabolised
may be dissolved. The water should be stirred until the
confusion, depression, taste disturbance, blurred
through CYP2C19 should be considered. An interaction
tablet disintegrates. The liquid with the pellets should
vision, bronchospasm, stomatitis, gastrointestinal
is observed between clopidogrel and esomeprazole.
be drunk immediately or within 30 minutes.
Longest acting: only GSL
Effective for nocturnal heartburn:
candidiasis, hepatitis with or without jaundice, alopecia,
The clinical relevance of this interaction is uncertain.
The glass should be rinsed with half a glass of water
medicine to offer sustained
Up to 4 out of 5 nights were
photosensitivity, arthralgia, myalgia, malaise, increased
The use of esomeprazole with clopidogrel should be
and the water drunk. The pellets should not be chewed
• Nexium Control® is a proton pump
24 hour heartburn protection
heartburn-free when taking
sweating. Very rare: agranulocytosis, pancytopenia,
discouraged. Patients should not take another PPI or
inhibitor (PPI) containing 20mg
aggression, hallucinations, hepatic failure, hepatic
H2 antagonist concomitantly.This medicinal product
from just one tablet a day.
Nexium Control for 14 days.4
Cost: Pack of 7 tablets RRP £6.99, pack of 14 tablets
encephalopathy in patients with pre-existing liver
contains sugar spheres (sucrose). Patients with rare
RRP £11.99.
disease, erythema multiforme, Stevens-Johnson
hereditary problems of fructose intolerance, glucose
• It works by reducing the production
syndrome, toxic epidermal necrolysis (TEN), muscular
galactose malabsorption or sucrase isomaltase
Targets the cause of heartburn,
Date: January 2015
of acid in the stomach, providing
Established and trusted: as
weakness, interstitial nephritis, gynaecomastia. Not
insuffi ciency should not take this medicine. The
not the symptom: by stopping the
24 hour protection from heartburn.
the number 1 acid blocker brand
known: hypomagnesaemia; severe hypomagnesaemia
increased Chromogranin A (CgA) level may interfere
worldwide, it has been used
proton pump from releasing acid
can correlate with hypocalcaemia; hypomagnesaemia
with investigations for neuroendocrine tumours. To
Forbes Consulting Groups Usage and Attitude Study 2013.
• Unlike antacids and alginates that
Based on market research January 2013 in 1001 frequent
by millions of patients.5
into the stomach, Nexium Control
may also result in hypokalaemia, microscopic colitis.
avoid this interference the esomeprazole treatment
heartburn sufferers, divided into fi ve segments based on
treat the symptoms of heartburn,
protects from the 3 main signals
should be temporarily stopped fi ve days before
attitudes on heartburn and treatment. Data on fi le.
Nexium Control® tackles the cause by
Precautions: Patients should be instructed to consult
CgA measurements.
Mandel KG et al. Aliment Pharmacol Ther. 2000;14:669-90.
that tell the body to make acid.
targeting acid directly at the source.
a doctor if: They have signifi cant unintentional weight
High level of satisfaction:
loss, recurrent vomiting, dysphagia, haematemesis
Contra-indications: Hypersensitivity to esomeprazole,
Fennerty et al. J Fam Pract. 2009 Jul;58(7 Suppl Short):S1-12.
8 out of 10 sufferers experienced
Nexium Control® Summary of Product Characteristics
• Nexium Control® starts to work
or melaena and when gastric ulcer is suspected or
substituted benzimidazoles or to any of the excipients.
IMS 2014 based on worldwide value sales data.
Recommended treatment -
in 1 hour and some people may
meaningful improvement in their
present, malignancy should be excluded as treatment
Esomeprazole must not be used concomitantly
NICE guidelines recommend PPIs
with esomeprazole may alleviate symptoms and delay
with nelfi navir.
NICE Guidelines CG184 Sept 2014 http://www.nice.org.uk/
experience protection from
heartburn symptoms during
as fi rst line prescription treatment
diagnosis. They have had previous gastric ulcer or
heartburn that day or by the evening.
short term treatment.4
Dosage and Method of use:
gastrointestinal surgery. They have been on continuous
The recommended dose
Boardman H et al. Partnership in optimizing management of
for undiagnosed heartburn.6
Full effect may take 2-3 days.
refl ux symptoms: a treatment algorithm for over-the-counter
symptomatic treatment of indigestion or heartburn
is 20 mg esomeprazole (one tablet) per day. It might
proton-pump inhibitors, Current Medical Research & Opinion
for 4 or more weeks. They have jaundice or severe
be necessary to take the tablets for 2 3 consecutive
Vol. 31, No. 7, 2015, 1309–1318
For further information about Nexium Control® please visit http://hcp.nexiumcontrol.co.uk
Data of preparation: September 2015
Source: http://www.scottishpharmacist.co.uk/wp-content/uploads/2014/06/Nexium-Advertorial-DPS_297x210mm_FINAL-V2.pdf
PRESCRIBING INFORMATION PrCATHEJELL® Jelly 2% (lidocaine hydrochloride jelly USP) Topical Anesthetic Pharmazeutische Fabrik Montavit Ges.m.b.H Date of Preparation: Salzbergstrasse 96 21 August 2014 6067 Absam, Austria www.montavit.com Distributed in Canada by: BioSyent Pharma Inc., Toronto, Ontario, Canada M9W 5Z5 Submission Control No: 176968
Pituitary 7: 83–87, 2004 2005 Springer Science + Business Media, Inc. Manufactured in The Netherlands. Pituitary Apoplexy During Therapy with Cabergoline in anAdolescent Male with Prolactin-Secreting Macroadenoma Mirta Knoepfelmacher, Miriam C. Gomes, Maria E.Melo, and Berenice B. MendoncaDepartment of Endocrinology, Hospital das Cl´ınicas, Universityof S ˜ao Paulo Medical School, S ˜ao Paulo, Brasil